Correlation Between Mineralys Therapeutics, and Dyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Dyne Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Dyne Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Dyne Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Dyne is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Dyne Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Dyne Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Dyne Therapeutics. In addition to that, Mineralys Therapeutics, is 1.1 times more volatile than Dyne Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Dyne Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 3,078 in Dyne Therapeutics on August 29, 2024 and sell it today you would lose (155.00) from holding Dyne Therapeutics or give up 5.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Dyne Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Dyne Therapeutics |
Mineralys Therapeutics, and Dyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Dyne Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
| Dyne Therapeutics vs. Eliem Therapeutics | Dyne Therapeutics vs. Scpharmaceuticals | Dyne Therapeutics vs. Milestone Pharmaceuticals | Dyne Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |